- 6
- 91 418
Ashok Jaiswal
India
เข้าร่วมเมื่อ 29 ต.ค. 2011
NAFLD to MASLD: What is in name?
Nonalcoholic fatty liver disease is characterized by excessive liver fat in absence of significant alcohol consumption and any other chronic liver diseases. The word fatty and nonalcoholic in this NAFLD are considered as stigmatizing. The word "nonalcoholic" is not capturing the exact underlying cause, i.e. insulin resistance and metabolic dysfunction, of NAFLD. Hence, the experts from global societies, including AASLD, EASL, APASL and others came together, creating a steering committee and a panel of experts, inclusive of hepatology, GI, endocrinology, etc to undertake a consensus document through Delphi method. As a end result of this consensus, MASLD (metabolic dysfunction associated steatotic liver disease) is chosen to replace word NAFLD. MASLD is defined as people with hepatic steatosis and presence of at least 1 out of 5 cardiometabolic risk factors in absence of excessive alcohol intake. A new category, called MetALD, has been created which includes the patients having MASLD along with history of excessive alcohol intake.
มุมมอง: 480
วีดีโอ
The Global Initiative for Asthma - GINA 2023 Updates
มุมมอง 43Kปีที่แล้ว
The updated GINA 2023 report has been released recently with new information and guidance on management of asthma. Some of the key changes include a clarification of terminology for asthma medications, e.g anti-inflammatory reliver (AIR), maintenance treatment, controller therapy, reliver medication, and MART. Maintenance and reliever therapy (MART) refers to a treatment regimen wherein ICS-for...
Comprehensive Management of NAFLD A Physician Perspective
มุมมอง 825ปีที่แล้ว
Nonalcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver disease and it has become the leading cause of hepatocellular carcinoma and liver transplantation in recent time. In India, almost 38% of general population suffer from NAFLD. The prevalence is very high in people having metabolic disorder like obesity, type 2 diabetes, dyslipidemia. The route cause behind ...
Role of ICS and place of triple therapy in COPD - GOLD 2023
มุมมอง 2.6Kปีที่แล้ว
Inhaled corticosteroid plays important role in the management of COPD patients having history of hospitalization due to COPD exacerbation, or history of two or more than two moderate COPD exacerbation, with blood eosinophil count of more than 300 cells/ul. The IMPACT and ETHOS studies have shown that triple therapy (ICS LABA LAMA) in a single inhaler therapy is associated with significant reduc...
NAFLD and clinical significance of grading fibrosis
มุมมอง 19Kปีที่แล้ว
NAFLD is associated with increased risk of CVD and liver related clinical events. Hence, it is important to do risk categorization of NAFLD patients. It is the fibrosis in liver which is directly related to major adverse liver events (like cirrhosis, decompensated liver failure, hepatocellular carcinoma, liver transplantation and mortality). Hence, risk categorization has to be done based on gr...
The GOLD 2023 COPD Guidelines What is new in it?
มุมมอง 26Kปีที่แล้ว
The Global Initiative for Chronic Obstructive Pulmonary Disease, i.e. The GOLD, has issued its updated 2023 reports on diagnosis, prevention and management of COPD in November 2022. There are certain differences in 2023 reports from 2022 reports. The definition of COPD is itself different and very appropriately, now it says that COPD is a heterogenous disease. The 2023 reports has also incorpor...
Thank you so much Dr. It helps me a lot😃
Measuring method, kpa or m/sec?
Love this! Thank you!
عاشت ايدك ❤
Thank you sir❤
Kindly mention the doses of formeterol max dose ,and dose of glycopyronium
Thank you for simplifying the concept. Would it be possible to share the slides?
I like it ,so helpful 😊
Great lecture. Thanks for sharing.
Glad it was helpful!
Thank you a lot ❤
Very very great lecture
Thanks for liking
Mine is 230 and 8.4. What is that?
CAP value of 230 is within the normal limit. LSM value of 8.4 is just borderline. Just knowing CAP and LSM values in isolation is not good enough. Are you a diabetic? What are your lipids values? Your BMI?
@@ashokjaiswal6470and 8.8 ?
Sir,good video
Thanks
Sir my fib 4 score is 1, and fatty liver grade 3, will it be reversable to grade 2 and 1 after losting weight about 10% of total body weight ???
Your fib 4 score indicates absence of advanced fibrosis. Weight loss of at least 10% and lifestyle changes should help you a lot in decreasing fat in the liver. Manage your blood sugar in case you have diabetes and control your blood lipids as well. Repeat fib 4 score at least annually. For further advice, you may consult your physician.
Excellent video sir... thanks a lot...
Thank you doctor for being so informative. One query though. In general how long does it take to progress from Nash to Fibrosis Level 0 or 1. Just a ballpark estimate...thanks
Great question. Usually it takes around 7 to 14 years for fibrosis to progress by 1 stage further. Its rate of progression depends on whether the patient is having diabetes or other comorbid conditions as well or not. In diabetes patients it progresses at a faster rate compared to non diabetic people.
@@ashokjaiswal6470 Thank You so much Sir for the response....It helps...
Very informative presentation 👌
Glad you liked it
Cap score 435 and kpa is 10.2 i am 26 yr old obese
I recommend you to have a consultation with a gastro or hepatologist
@@ashokjaiswal6470 I am using saroglitazar 4 mg od from 6 months can you recommend any good hepatologist in India ?
Doctor, What does a nafld fibrosis blood test score of -2.80 mean? Thank you in advance
NAFLD fibrosis score of < - 0.145 indicates absence of significant fibrosis in liver; score > 0.675 is a predictor of presence of significant fibrosis; and score in between is an indeterminate score.
@@ashokjaiswal6470 Thank you Doctor, But what does -2.80 mean? that is the score Quest Diagnostics gave me, and I can't find another score like it anywhere
The nafld fibrosis score of minus 2.80 means there is no significant fibrosis in your liver tissue. It is good to have this score.
🙏
Sir you r great ❤❤
Sir plz make more and more video like this
Superb sir
Thank you very much Sir
Greeeeeat,can you tell me your source?
Asthma treatment has been very complicated i haven't able to understand it till now
True
Thank you, this is easy to understand!
Very helpful. Thank you sir
thank u for the help ! - pharmacy student
Sir mai Fibroscan karta hu Jaypee hospital Noida
Thank you so much, i have a question is the reliever now changed to LABA + ICS instead of SABA for emergency cases for ex
Thank you sir
This was amazing! You made it so simple to understand the different treatment plans. Thank you so much for your explanation!
I enjoyed this. Thank you
Kpa 9.8 and cap 347..is it reversible?
Abhi kaisa hai report
Hi, quick Q, ICS should be control therapy in COPD. I didn’t understand why there is criteria to add ics that is shown in colorful chart. Please help me to understand
No one in this universe explained GINA classification so precisely....❤
Glad you find it useful 👍
GOLD is NOT a Guideline, it's a strategy document and a report
Thank you, sir
How to plateletes value change 10 9
Respected sir, iam suffer from diabeteic about 1 year,my LFT show alt value 22.39 , ast value 23.45 platelets 150000 mpv 52 lipid parameter total colestsral 245 ldl 197 tg182 non hdl210, fib 4 score1.67 recently consult hepatogist at Aig hospital Hyderabad he tested fibroscan test my lsm value 4.5 cap score295. My dr precribe Metfor 500 , rusuvastatin 5 mg , bilypsa 4mg for daily, with life style change . Sir I continue bilypsa for low platelets it is saftey and effective, how much time I use long run it is useful please suggest continue thease medicines or change and add another medicine.
I would suggest you to continue treatment as recommended by your treating doctor. Regarding bylipsa, I.e. saroglitazar molecule, it has been studied in non-alcoholic fatty liver disease and it is approved in India for NAFLD. Studies have shown its safety and efficacy and it can be continued for at least 1 year. Follow the treatment of your doctor and most important is adopting healthy lifestyle and managing body weight.
Saroglitazar would also help in controlling your abnormal lipids, in particularly hight TG and non hdl values along with insulin resistance of type 2 diabetes.
Thank you sir
Good morning sir I subbareddy suffering diabetes and fatty liver ,I used bilypsa 4mg from 1year sir i continue bilypa day after day or weekly thrice for another one year please suggest sir
Great presentation Dr Ashok. I was struggling to understand the treatment options. You summarized it perfectly, thank you.
I'm glad it was helpful
Very helpful sir
Thank you very much very helpful
❤
Thank you so much Dr.Ashok this was very helpful 👍🏻
Glad it was helpful!
excellent, ty
sir i need this powerpoint how can i get it thanks in advance
Sir my age is 37 , have hepatitis B kpa is 23 What shell i do